Literature DB >> 25572778

Exceptional responders: in search of the science behind the miracle cancer cures.

Ishwaria Mohan Subbiah1, Vivek Subbiah.   

Abstract

Entities:  

Keywords:  exceptional responder; genomics; next-generation sequencing; outlier responder; unusual responder

Mesh：

Year:  2015        PMID： 25572778     DOI： 10.2217/fon.14.204

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  5 in total

1.  Debunking the Delusion That Precision Oncology Is an Illusion.

Authors:  Vivek Subbiah; Razelle Kurzrock
Journal:  Oncologist       Date:  2017-05-26

Review 2.  Personalized targeted therapy for esophageal squamous cell carcinoma.

Authors:  Xiaozheng Kang; Keneng Chen; Yicheng Li; Jianying Li; Thomas A D'Amico; Xiaoxin Chen
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.

Authors:  Vivek Subbiah; Michael J Wagner; Mary F McGuire; Nawid M Sarwari; Eswaran Devarajan; Valerae O Lewis; Shanon Westin; Shumei Kato; Robert E Brown; Pete Anderson
Journal:  Oncotarget       Date:  2015-12-01

4.  Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.

Authors:  Kunal C Kadakia; Scott A Tomlins; Saagar K Sanghvi; Andi K Cani; Kei Omata; Daniel H Hovelson; Chia-Jen Liu; Kathleen A Cooney
Journal:  J Hematol Oncol       Date:  2015-10-06       Impact factor: 17.388

Review 5.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.